During the past decade, Helsingborg General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helsingborg General Hospital" #1 collaborator was "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator, "European Myeloma Network" with 1 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator and "Lund University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Helsingborg General Hospital" are "Acute Coronary Syndrome" (1 trials), "Chest Pain" (1 trials), "Decompensated Heart Failure" (1 trials), "Heart Failure" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Helsingborg General Hospital" in a lesser frequency.

Most popular intervention types in "Helsingborg General Hospital" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "0h/1h hs-cTnT protocol" (1 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "Bortezomib, Melphalan, Prednisone (VMP)" (1 trials) and "Echocardiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helsingborg General Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Helsingborg General Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Helsingborg General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Helsingborg General Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".